Independent · evidence-anchored·Reviewed by the GLPHelper Medical Team
EN·ES
glp·helper
Find a Provider →
glphelper.com/ozempic/rhode-island/warwick
GLP-1 receptor agonistFDA-approved December 2017Rx · Subcutaneous injection · Once weekly

Ozempic® providers &
prescriptions in Warwick, RI

Verified Ozempic providers in Warwick, RI. Checked against the NPI registry, sorted by waitlist, not by who pays us.[7]

average Ozempic weight loss →trial-anchored estimate
city providers
32
as of today
median wait
8d
first visit
telehealth
71%
of providers
cash range
$25 to $1,150
monthly
§ 02Provider directory: Rhode Island
32 of 32 shown

Find an Ozempic provider in Rhode Island.

Every entry is checked against the NPI registry and the Rhode Island medical board. Listings are ordered by current waitlist. The provider who can see you fastest appears first. We do not accept payment for placement.

Filter →
Type
Provider
City
Waitlist
Insurance
Browse by Rhode Island city · /ozempic/rhode-island/{city}
Cranston
26 →
Providence
39 →
§ 03Getting Ozempic in Warwick
32 providers · Warwick, RI

How to get Ozempic in Warwick.

32 GLP-1 prescribers and 7 local resource types are on record for Warwick, plus 2 nearby towns in the directory.

Prescribers in Warwick
32 prescribers
32 GLP-1 prescribers in Warwick, most listed as Family Medicine (13), Internal Medicine (10) and Internal Medicine, Endocrinology, Diabetes & Metabolism (7). Any Rhode Island-licensed physician, nurse practitioner, or PA can prescribe Ozempic, over video or in person. The nearest towns on record are Cranston (26 providers) and Providence (39 providers).
Around the prescription in Warwick
7 listed nearby
6 dietitians, 2 nutritionists, 6 gyms, 6 fitness clubs, 6 trainers, 6 physiotherapists and 6 places to move are on record near Warwick.
Medicaid (weight loss)
Covered
As of April 2026, Rhode Island Medicaid covers GLP-1s for weight loss, usually with prior authorization and BMI criteria, on top of the standard diabetes coverage. Employer and private plans vary; coverage is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Rhode Island’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for adults with type 2 diabetes, and, by indirect effect, for body weight.

Ozempic is the brand name for semaglutide, a once-weekly subcutaneous injection in the GLP-1 receptor agonist class. It mimics a gut hormone that signals satiety to the brain and slows gastric emptying. In randomized trials it lowered HbA1c by 1.4 to 1.8 percentage points and produced a mean weight loss of 4.5 to 6.4 kg at the 1 mg dose.[2][3]

It is FDA-approved for glycemic control in adults with type 2 diabetes mellitus and for reducing the risk of major cardiovascular events in adults with T2D and established cardiovascular disease. The same molecule, marketed by the same manufacturer as Wegovy, is the FDA-approved formulation for chronic weight management.[1]

For the receptor story in plain English, read how does ozempic work.

Rapid weight loss can change the midface. The mechanism people call ozempic face is in the research notes.

At a glanceNDC 0169-4132
Generic name
semaglutide
Drug class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
FDA approved
December 2017
Approved use
Type 2 diabetes mellitus (adults)
Off-label use
Weight management (Wegovy is the FDA-approved formulation for obesity)
Administration
Subcutaneous injection · Once weekly
Available doses
0.25 mg · 0.5 mg · 1 mg · 2 mg
Half-life
≈ 7 days
Pregnancy
Discontinue ≥ 2 months before planned pregnancy

Community health · CDC

Weight & metabolic health in Rhode Island

Diagnosed diabetes reaches 10% of adults in Rhode Island.

of Rhode Island adults have obesity
31.1%
diagnosed diabetes
10%

Age-adjusted estimates for Rhode Island, community figures, not individual risk. CDC BRFSS 2024.

Estimate your weight losswhat happens after GLP-1s stop
§ 05Support around Ozempic in Warwick
6 dietitians

The prescription is one part. Here is the rest, in Warwick.

Trials of semaglutide paired the drug with diet counseling and regular activity. Every name below is a real listing near Warwick, RI, ordered as the registry lists them, never by who pays us.

Registered dietitians

A registered dietitian builds the food plan around your prescription. Call to ask about GLP-1 nutrition plans and insurance.

Michelle Anderson
RD
Registered dietitian
2191 Post Rd
Call 401-732-3066NPI 1477582971
Betsy Barbera
RD
Registered dietitian
2191 Post Rd
Call 401-732-3066NPI 1255364071
Diana Beaton, R.D
RD
Registered dietitian
869 Post Rd
Call 401-439-1028NPI 1619201985
Julia Berman-Pare, RD, LDN
RD
Registered dietitian
87 Newfield Ave
Call 401-499-8157NPI 1023562501
Julia Bodah, RD
RD
Registered dietitian
2 Dudley St Fl 5
Call 401-274-1122NPI 1275484222
Linda Carro, RD, CDOE
RD
Registered dietitian
455 Toll Gate Rd
Call 401-736-4678NPI 1871502526

Nutritionists

A nutritionist helps you get enough protein and fiber while the medication cuts your appetite. Call to ask what they cover.

Catherine Jarvie, RD LDN
NUTRITIONIST
Nutritionist · Education
34 Urban Ave
Call 401-241-5510NPI 1992972921
Jennifer Marchand, RD LDN
NUTRITIONIST
Nutritionist
75 Lambert Lind Hwy
Call 401-681-4274NPI 1225602840
§ 06Clinical evidence
N = 8,416 across SUSTAIN 1 to 7

What the trials actually showed.

We summarize results from the SUSTAIN program, the seven Phase III randomized trials Novo Nordisk submitted to the FDA, and the SUSTAIN-6 cardiovascular outcomes trial. Numbers below are means at the 30-week endpoint, 1 mg weekly dose.

SUSTAIN 1 through 7 compared semaglutide against placebo, sitagliptin, exenatide ER, insulin glargine, and dulaglutide. Semaglutide produced superior HbA1c and body-weight reductions in every active comparator trial.[3]
SUSTAIN endpoint table1 mg / 30 wk
HbA1c reduction
−1.4 to −1.8%
vs. placebo at 30 wk[3]
Weight change
−4.5 to −6.4 kg
mean, 1 mg dose[3]
Major adverse cardiac events
−26%
HR 0.74 vs. placebo[2]
Patients reaching HbA1c <7%
72%
1 mg dose, 30 wk[3]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Ozempic weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in SUSTAIN trials were nausea (15 to 20%), diarrhea (8 to 9%), and vomiting (5 to 9%), all dose-dependent and typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Contraindicated in personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
15 to 20%
mild
Most common; typically dose-dependent and resolves within weeks
Diarrhea
8 to 9%
mild
More frequent during dose escalation
Vomiting
5 to 9%
mild
Reduced by slower titration
Constipation
3 to 7%
mild
Abdominal pain
5 to 7%
moderate
Pancreatitis
<0.3%
serious
Discontinue if confirmed; black-box adjacent
Gallbladder disease
1.5%
serious
Cholelithiasis risk elevated with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated in MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Cash (no insurance)
$950 to $1,150
per month
National pharmacy average, brand-name[6]
Commercial insurance (covered)
$25 to $250
per month copay
Varies by PBM; T2D indication usually covered
Commercial insurance (off-label / weight)
Typically denied
PA required; majority denied for weight indication
Medicare Part D
$0 to $100
per month
T2D covered; weight loss not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial only; eligibility limits apply
Compounded semaglutide
$150 to $400
per month
503A pharmacies; FDA scrutiny ongoing[8]
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Ozempic providers in Rhode Island

NPI-verified Ozempic (semaglutide) prescribers and clinics, ordered by availability, never by who pays us.

Weight loss doctors in Rhode Island
Board-certified prescribers verified against the NPI registry.
Weight loss clinics in Rhode Island
Clinics running GLP-1 programs, telehealth & in-person.
Ozempic in other states

Find NPI-verified Ozempic (semaglutide) doctors, clinics, and pharmacies in the states we cover, ordered by availability, never by who pays us.

Ozempic in Alabama→Ozempic in Alaska→Ozempic in Arizona→Ozempic in Arkansas→Ozempic in California→Ozempic in Colorado→Ozempic in Connecticut→Ozempic in Delaware→Ozempic in Florida→Ozempic in Georgia→Ozempic in Hawaii→Ozempic in Idaho→Ozempic in Illinois→Ozempic in Indiana→Ozempic in Iowa→Ozempic in Kansas→Ozempic in Kentucky→Ozempic in Louisiana→Ozempic in Maine→Ozempic in Maryland→Ozempic in Massachusetts→Ozempic in Michigan→Ozempic in Minnesota→Ozempic in Mississippi→Ozempic in Missouri→Ozempic in Montana→Ozempic in Nebraska→Ozempic in Nevada→Ozempic in New Hampshire→Ozempic in New Jersey→Ozempic in New Mexico→Ozempic in New York→Ozempic in North Carolina→Ozempic in North Dakota→Ozempic in Ohio→Ozempic in Oklahoma→Ozempic in Oregon→Ozempic in Pennsylvania→Ozempic in Rhode Island→Ozempic in South Carolina→Ozempic in South Dakota→Ozempic in Tennessee→Ozempic in Texas→Ozempic in Utah→Ozempic in Vermont→Ozempic in Virginia→Ozempic in Washington→Ozempic in West Virginia→Ozempic in Wisconsin→Ozempic in Wyoming→
Related GLP-1 research
how Ozempic works in the body
Mechanism, appetite signaling, and why the dose schedule matters.
why facial fat loss happens
Facial fat loss on GLP-1s: causes, prevention, and reversibility.
Ozempic side effects in men
Male-specific effects: muscle, testosterone, and sexual health.
§ 09Frequently asked: Ozempic in Rhode Island

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Yes. Semaglutide is a federally scheduled prescription drug in all 50 states. A licensed prescriber (MD, DO, NP, or PA) must evaluate you before issuing a prescription. No state permits pharmacist-initiated prescribing of GLP-1s.[1]